Coming Soon
Learn about Adrenal Incidentaloma diagnosis, including clinical documentation, medical coding, and healthcare best practices. This resource covers Adrenal Nodule and Adrenal Mass, providing information for accurate diagnosis and coding of adrenal incidentalomas. Find guidance on appropriate medical terminology and documentation for optimal patient care and accurate clinical records related to adrenal incidentalomas.
Also known as
Other adrenal disorders
Covers other specified disorders of the adrenal gland.
Neoplasm of uncertain behavior of adrenal gland
Classifies adrenal tumors whose benign or malignant potential is uncertain.
Abnormal findings on diagnostic imaging of other adrenal glands
Describes unusual results from adrenal imaging studies (like CT or MRI).
Benign neoplasm of adrenal gland
Identifies non-cancerous growths within the adrenal gland.
Follow this step-by-step guide to choose the correct ICD-10 code.
Is the adrenal incidentaloma functional?
When to use each related code
| Description |
|---|
| Adrenal gland mass found incidentally on imaging. |
| Non-cancerous adrenal tumor producing excess hormones. |
| Cancerous tumor of the adrenal gland. |
Incidentalomas require confirmatory imaging and/or biopsy to rule out malignancy, impacting accurate coding (e.g., D35.0 vs. C74). This poses CDI and compliance risks.
Coding requires specifying laterality (right, left, bilateral). Missing laterality information for adrenal incidentalomas leads to coding errors and claim denials.
Distinguishing functional (e.g., hormone-secreting) from non-functional incidentalomas is crucial for correct coding and impacts medical necessity reviews for further workup.
Q: What is the most effective imaging protocol for characterizing an incidentally discovered adrenal mass and differentiating between benign adrenal adenoma and other adrenal lesions like pheochromocytoma or adrenocortical carcinoma?
A: Characterizing an incidentally discovered adrenal mass requires a multi-modal approach. While unenhanced CT is often the initial imaging modality, further evaluation depends on size and imaging characteristics. For masses < 4cm with benign features (e.g., low attenuation on unenhanced CT), hormonal evaluation is recommended. For larger masses or those with suspicious features (e.g., irregular margins, heterogeneous enhancement), contrast-enhanced CT or MRI is warranted. Chemical shift MRI can aid in differentiating adrenal adenoma from other lesions. In cases where pheochromocytoma is suspected, consider plasma or urinary metanephrines and normetanephrines. If adrenocortical carcinoma is a concern, serum cortisol, DHEAS, and aldosterone levels may be useful. Explore how S10.AI can integrate these imaging and hormonal data points to assist in risk stratification and clinical decision-making for adrenal incidentaloma management.
Q: When should surgical intervention be considered for an adrenal incidentaloma and what factors influence the decision between adrenalectomy vs. active surveillance for patients with non-functioning adrenal adenomas?
A: The decision for surgical intervention versus active surveillance for an adrenal incidentaloma depends on several factors, including functionality, size, and imaging characteristics. Functioning tumors, such as those causing Cushing's syndrome or primary aldosteronism, typically require surgical removal. Non-functioning adenomas < 4cm with benign imaging features (e.g., homogenous, low attenuation on CT) can often be managed with active surveillance, including repeat imaging and hormonal assessment at intervals. However, surgical intervention should be considered for non-functioning adenomas > 4cm or those demonstrating concerning imaging features such as rapid growth, irregular borders, or heterogeneous enhancement, as these raise the suspicion for malignancy. Consider implementing S10.AI's insights to facilitate patient-specific risk assessment and guide decisions regarding surgical intervention vs. active surveillance.
Patient presents with an adrenal incidentaloma, an incidentally discovered adrenal mass or adrenal nodule, found during imaging performed for reasons unrelated to adrenal function. The patient's chief complaint for the original imaging study was (reason for initial imaging). The adrenal incidentaloma was identified on (imaging modality, e.g., CT abdomen, MRI abdomen) and is described as (size, location, and characteristics of the incidentaloma, e.g., a 1.5 cm, well-circumscribed, homogenous, right adrenal mass). Patient denies any symptoms suggestive of adrenal hormone excess, such as hypertension, weight gain, muscle weakness, easy bruising, or hirsutism. No history of adrenal disorders. Review of systems is otherwise unremarkable. Differential diagnosis includes benign adrenal adenoma, adrenocortical carcinoma, pheochromocytoma, myelolipoma, and metastasis. Further evaluation to characterize the adrenal incidentaloma is recommended and will include biochemical evaluation for hormone overproduction including assessment of serum metanephrines, plasma aldosterone concentration and plasma renin activity, and a 24-hour urine collection for free cortisol. Follow-up imaging with (imaging modality) in (timeframe) is planned to assess for growth. Patient education provided regarding adrenal incidentalomas, including the importance of follow-up and potential management options. ICD-10 code D44.7 (neoplasm of uncertain behavior of adrenal gland) may be applicable, pending further evaluation. CPT codes for imaging and laboratory tests will be documented separately.